Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.05M Buy
5,655
+186
+3% +$63.7K 0.26% 90
2026
Q1
$1.92M Sell
5,469
-351
-6% -$125K 0.28% 84
2025
Q4
$1.91M Sell
5,820
-17
-0.3% -$5.39K 0.28% 83
2025
Q3
$1.65M Sell
5,837
-61
-1% -$17.7K 0.24% 97
2025
Q2
$1.65M Buy
5,898
+65
+1% +$18.4K 0.27% 84
2025
Q1
$1.82M Buy
5,833
+2,716
+87% +$802K 0.34% 70
2024
Q4
$812K Buy
3,117
+185
+6% +$54.9K 0.19% 103
2024
Q3
$945K Buy
2,932
+130
+5% +$42.5K 0.23% 94
2024
Q2
$875K Buy
2,802
+104
+4% +$30.6K 0.23% 89
2024
Q1
$767K Buy
2,698
+196
+8% +$57.4K 0.21% 92
2023
Q4
$721K Buy
2,502
+83
+3% +$22.6K 0.63% 39
2023
Q3
$650K Buy
+2,419
New +$604K 0.21% 85

Other funds holding AMGN

KPP Advisory Services's AMGN Position: Q2 2026 in Review

KPP Advisory Services increased its Amgen (AMGN) stake by 3.4% in Q2 2026, buying an estimated $63.7K and bringing the position to 5,655 shares worth $2.05M. The position accounts for 0.26% of the portfolio, ranked #90.

KPP Advisory Services first reported a position in AMGN in Q3 2023 and has held it in 12 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • KPP Advisory Services held 5,655 shares of Amgen worth $2.05M as of Q2 2026.
  • KPP Advisory Services bought 186 Amgen shares in Q2 2026, an estimated $63.7K.
  • Amgen made up 0.26% of KPP Advisory Services's portfolio in Q2 2026, its #90 holding.
  • KPP Advisory Services first reported a position in Amgen in Q3 2023 and has held it in 12 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on KPP Advisory Services's 13F filing for Q2 2026, filed 24 Jul 2026.